NewWeight Loss
SKU: PCUK-RT30
Retatrutide 30mg is the single 30mg lyophilised vial in the UK catalogue. Compare its labelled amount, current price and available report with the smaller vial formats.
£119.99 by bank transfer (4% off) · £114.99 by crypto (8% off), applied at checkout
✓Free standard delivery on orders of £75 or more
✓Tracked UK delivery, Standard £4.99 / Express £9.99
✓In-stock orders: same-day dispatch before 2pm UK, Monday–Friday excluding bank holidays
Delivery thresholds use the goods subtotal before discounts. Optional signed delivery costs extra. Delivery terms · Returns policy
This product supplies Retatrutide as one lyophilised vial labelled 30mg. The compound is also referred to as Reta or LY3437943; the 30mg designation identifies this particular catalogue quantity.
The 30mg format is one container, not a pack of three 10mg vials and not the Retatrutide Bundle Kit. Container count matters when specifying laboratory materials, even when two purchases have the same total labelled mass.
Use the current price and quantity to compare purchasing formats, then check the report associated with each listing separately. Do not infer a shared batch, purity percentage or solution concentration from the compound name or vial size.
A report is currently linked for batch 100236. Open the published report below to check its sample identity, reference, methods and results. A report describes the tested sample and does not establish sterility, suitability for personal use or results from tests it does not contain.
This is a laboratory research material for non-clinical in-vitro work. Do not ingest, inject, inhale, apply or otherwise administer it to a human or animal. Laboratory handling must follow a validated institutional SOP and risk assessment.
| Compound | Retatrutide (30mg) |
| CAS Number | 2381089-83-2 |
| Category | Metabolic Research |
| Sequence | LY3437943 (proprietary triple receptor agonist sequence; see COA for full data) |
| Purity | 99.831% (CoA reported, HPLC) |
| Form | Lyophilised powder |
| Appearance | White/off-white lyophilised powder |
| Quantity | 30mg / vial |
| Storage (Lyophilised) | −20°C for long-term storage |
| Storage Conditions | Keep the material sealed and follow the storage conditions on its label and available batch documentation. Prepared-sample conditions and stability depend on a validated laboratory SOP; this page does not specify a universal shelf life after preparation. |
| Batch | 100236 |
| SKU | PCUK-RT30 |
⚠ Retatrutide (30mg) is supplied solely for lawful non-clinical in-vitro laboratory research. It is not licensed by the MHRA for medicinal use and must not be used in or on a human or animal. No diagnosis, treatment, prevention, cosmetic or in-vivo use is offered. You must be 18 or older to purchase.
Compare the listed supplied quantities, live prices, stock and batch-document status. Quantity is a procurement format, not dosing or use guidance.
Lab Supplies
In StockBAC Water 10mL is an aqueous laboratory supply containing 0.9% benzyl alcohol. The 10mL label is a liquid volume, distinct from a peptide vial's mass in milligrams. Supplied solely for non-clinical in-vitro laboratory research. Not for use in or on humans or animals.
SKU: PCUK-BAC10
Recovery & Repair
In StockBPC-157 + TB-500 10mg is a single lyophilised blend vial, labelled as 5mg of each component. The 10mg total is not 10mg of each peptide. Supplied solely for non-clinical in-vitro laboratory research. Not for use in or on humans or animals.
SKU: PCUK-BPCTB10
Skin & Anti-Ageing
In StockKLOW Research Blend 80mg is a single lyophilised multi-component vial. Review its labelled total and the component information in the available report separately. Supplied solely for non-clinical in-vitro laboratory research. Not for use in or on humans or animals.
SKU: PCUK-KLOW80
One vial labelled as 30mg of lyophilised Retatrutide. It is not three 10mg vials and does not include a separate water vial.
No. It contains a larger labelled mass of dry material than the 10mg and 20mg formats, but no prepared liquid volume is specified. Mass per vial and solution concentration are different measurements.
Do not assume that it does. Check the batch reference and available report on this particular listing; another vial format's certificate is not automatically evidence for this one.
Reta and R3TA are shorthand for Retatrutide used in peptide listings. RT3 may also be used there, but is ambiguous. Confirm Retatrutide (LY3437943), the 30mg quantity and this listing's report; none of these abbreviations establishes a vial size, batch or prepared concentration by itself.
Retatrutide (30mg) is currently in stock. The current listed price is £124.99 per vial. Delivery charges and any applicable order discounts are calculated separately at checkout; the product price is not a delivered-order total.
A report is currently linked for batch 100236. Open the published report below to check its sample identity, reference, methods and results. A report describes the tested sample and does not establish sterility, suitability for personal use or results from tests it does not contain.
Keep the material sealed and follow the storage conditions on its label and available batch documentation. Prepared-sample conditions and stability depend on a validated laboratory SOP; this page does not specify a universal shelf life after preparation.
Supplied solely for non-clinical in-vitro laboratory research. Not for use in or on humans or animals. We do not provide dosing, administration, cosmetic-use or in-vivo protocols. Laboratory handling must follow a validated institutional SOP and risk assessment.